- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03696589
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease (Preactive-PD)
August 26, 2020 updated by: Lori Quinn, Teachers College, Columbia University
Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Improving Self-efficacy, Automaticity, and Physical Activity Levels in People With Parkinson's Disease
The purpose of this study is to assess the feasibility, in regards to acceptability and implementation, of the Pre-Active PD intervention for increased high intensity goal-directed aerobic exercise engagement in people with early-stage Parkinson's disease (Hoehn and Yahr stage I & II).
In addition, the study aims to explore the effect estimates of the Pre-Active PD intervention on self-efficacy, motivation, stage of behavior change, and physical activity levels in people with early stage Parkinson's disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators will recruit 14 individuals with early stage Parkinson's disease (Hoehn and Yahr stage I & II).
The investigators will conduct a single arm cohort.
(pre and post intervention) pilot feasibility study over 4 months with embedded process analyses of Preactive-HD, a physical activity coaching intervention program.
Previous studies conducted by the investigators will be utilized to adapt the Engage-HD physical activity coaching program to people with early stage PD.
The intervention will include a participant/coach interaction and disease-specific workbook grounded within the framework of self-determination theory.
The coaching sessions will be conducted by an occupational therapist and will entail six coaching sessions (either face-to-face or remote video sessions via secure Webex connection via computer or smart phone, or phone call if internet/smart phone is not available to participant).
The first session (approximately 45 min) will lay the groundwork for the program, and the remaining sessions will serve to provide directed support in relation to regular physical activity and exercise.
Participants will develop physical activity goals and will be supported with individual physical activity progression.
Participants will be given Fitbit devices as a motivational tool and to track activity progression.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10027
- Teachers College, Columbia University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Neurologist confirmed clinical dx for Parkinson's disease Hoehn & Yahr stage I or II
- Ambulatory for indoor and outdoor mobility without assistance or assistive device
- Successful completion of Physical Activity Readiness Questionnaire (PAR-Q) (Thomas et al., 1992), or medical clearance from GP
Exclusion Criteria:
- Musculoskeletal injury that would prevent participation in an exercise program
- Other neurological disease or disorder such as stroke
- Already engaging in aerobic exercise for at least 30 minutes for 5 or more days per week.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline Moderate-Vigorous Physical Activity Using Actigraph at 4 Months
Time Frame: baseline and 4 months
|
Measured using Actigraph accelerometer, levels of moderate-vigorous physical activity will be measured, as well as number of steps and sedentary behavior.
|
baseline and 4 months
|
|
Change From Baseline in the Behavioural Regulation In Exercise Questionnaire (BREQ-2)
Time Frame: baseline and 4 months
|
The BREQ-2 is a 19-item questionnaire that measures each of the subscales of the self-determination continuum: external, introjected, identified, and intrinsic regulations, as well as amotivation.
Each subscale is represented by 4 questions, except for introjected regulation which has 3. Questions are scored using a 5-point Likert scale; Answers range from 0 (not true for me) to 4 (very true for me).
Composite scores were calculated from these subscales.
Autonomous motivation was calculated from the intrinsic motivation and identified regulation subscales, with possible scores ranging from 0 (low autonomous motivation) to 4 (high autonomous motivation.
Controlled motivation was calculated from the introjected regulation and external regulation subscales, with possible scores ranging from 0 (low controlled motivation) to 4 (high controlled motivation).
|
baseline and 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline Timed-up-and-go (TUG) at 4 Months
Time Frame: baseline and 4 months
|
Participant starts sitting in chair and then rises when prompted to "go" and then walks 3 meters, turns around, and walks back to chair.
Time to complete is recorded
|
baseline and 4 months
|
|
Change From Baseline 6 Minute Walk Test at 4 Months
Time Frame: baseline and 4 months
|
Assesses the distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
|
baseline and 4 months
|
|
Change From Baseline Brunel Lifestyle Inventory at 4 Months
Time Frame: baseline and 4 months
|
The Brunel lifestyle inventory is a 10-item questionnaire that measures both pre-planned (6 items) and un-planned (3 items) lifestyle PA.
Scoring for each item is on a scale of 1-5, and the scores for each subscale are averaged.
Scores range from 1 (low level of physical activity) to 5 (high level of physical activity).
|
baseline and 4 months
|
|
Change From Baseline Wechsler Adult Intelligence Scale -III (WAIS-III) Digit Span Forward and Backward at 4 Months
Time Frame: baseline and 4 months
|
This test evaluates the number of digits a person can remember in both a forward and backward recall.
WAIS-III subscale measures sequential processing, mental manipulation, attention, concentration, memory span, and short-term auditory memory.
Higher numbers would indicate a greater number of digits remembered (better outcome).
Minimum value is 0 and there is no maximum.
|
baseline and 4 months
|
|
Change From Baseline Stroop Color-Word Interference at 4 Months
Time Frame: baseline and 4 months
|
This test evaluates the ability to state the color of a word but not the written word.
The cognitive dimension tapped by the Stroop is associated with cognitive flexibility, resistance to interference from outside stimuli, creativity, and psychopathology.
The number of correct words in 45 seconds is recorded.
|
baseline and 4 months
|
|
Change From Baseline Canadian Occupational Performance Measure (COPM) at 4 Months
Time Frame: baseline and 4 months
|
Designed to capture a client's self-perception of performance in everyday living, over time.
Participants rate their performance and satisfaction of previously defined goals on a scale of 1-10, with 10 being high performance or satisfaction, and 1 being low performance or satisfaction.
|
baseline and 4 months
|
|
Change From Baseline Exercise Self Efficacy Questionnaire at 4 Months
Time Frame: baseline and 4 months
|
18-item test that measures an individual's self-efficacy to participate in exercise when numerous barriers are present, including both social and physical barriers.
Total score is calculated by summing the responses to each question.
This scale has a range of total scores from 0-90.
A higher score indicates higher self-efficacy for exercise.
|
baseline and 4 months
|
|
Perceived Autonomy Support Healthcare Climate Questionnaire (HCCQ) at 4 Months
Time Frame: 4 months
|
The Perceived Autonomy Support Healthcare Climate Questionnaire is from the Health-Care, Self-Determination Theory Questionnaire Packet that was designed to assess constructs encompassed within Self-Determination Theory (SDT) as it applies to health-care behavior.
This is a measure of acceptability of the intervention administered only the 4 month assessment.
Scores on this 15-item questionnaire are calculated by averaging the individual item scores, which are rated on a 1-7 Likert scale.
Scores range from 1-7, with higher average scores (7 max) represent a higher level of perceived autonomy support.
|
4 months
|
|
Semi-Structured Post-intervention Questionnaire
Time Frame: 4 months
|
This purpose developed post-intervention questionnaire will evaluate participant's perceptions of the intervention.
Informed by the Theoretical Framework of Acceptability, the questionnaire was designed to inductively evaluate the retrospective acceptability of the intervention.
Score on Likert scale 1-5, with 5 being most acceptable.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lori Quinn, EdD, PT, Teachers College, Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 21, 2018
Primary Completion (Actual)
April 5, 2019
Study Completion (Actual)
April 12, 2019
Study Registration Dates
First Submitted
September 10, 2018
First Submitted That Met QC Criteria
October 2, 2018
First Posted (Actual)
October 4, 2018
Study Record Updates
Last Update Posted (Actual)
September 16, 2020
Last Update Submitted That Met QC Criteria
August 26, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-345
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Mission TherapeuticsMichael J. Fox Foundation for Parkinson's Research; Parkinson's UKRecruitingParkinson's Disease (PD) | Early Stage Parkinson's Disease | Mild to Moderate Parkinson's DiseaseUnited Kingdom
Clinical Trials on Physical Activity Coaching
-
Universitaire Ziekenhuizen KU LeuvenDutch Health Care Insurance BoardCompletedDiabetes Mellitus, Type 2Belgium
-
Teachers College, Columbia UniversityActive, not recruitingCerebellar AtaxiaUnited States
-
Stanford UniversityGoogle LLC.WithdrawnCardiovascular HealthUnited States
-
University of MinnesotaCompleted
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)Completed
-
Teachers College, Columbia UniversityColumbia UniversityActive, not recruitingParkinson DiseaseUnited States
-
Teachers College, Columbia UniversityCompleted
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques... and other collaboratorsUnknownParkinson's DiseaseFrance
-
Singapore General HospitalSingapore Health ServicesNot yet recruitingMild Cognitive Impairment (MCI) | Mild Cognitive Impairment